November 1, 2022
FDA: Five companies are having amoxicillin shortages
Editor's Note
As of November 1, the Food and Drug Administration (FDA) listed 26 amoxicillin products on its current drug shortages site. The FDA says increased demand is the largest cause of the shortage.
The FDA does not list resupply dates, but the American Society of Health-System Pharmacists (ASHP) estimates resupply dates for Hikma products (August 2023), Sandoz products (cannot estimate a release date), and Teva products (November and December 2022).
Free Daily News
- Study: ERAS protocol reduces opioid use after cardiac surgery
- Study: Prehabilitation reduces surgical complications, speeds recovery
- Commentary: Studies show how surgeon decisions follow the money
- Proposed HIPAA updates would improve cybersecurity, increase costs for healthcare providers
- Study: EMR data can enhance hand hygiene compliance, infection prevention
- Study: Machine learning model improves perioperative pain assessment
- Call for improved suicide risk screening in ASCs aims to strengthen safety protocols
- Study: Perioperative pregabalin reduces risk of kidney decline compared to gabapentin
- Medical school diversity declines after Supreme Court ruling
- Surgeons risk losing ground as transcatheter tricuspid valve interventions rise
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement